CLINICAL_TRIALS
trial_result
· 2016-06-17
Clinical Trial Update: A Clinical Trial of COX and EGFR Inhibition in Familial Polyposis Patients [Phase 2]
Summary
Phase 2 trial evaluating COX and EGFR inhibition in familial adenomatous polyposis; the study has been completed and results posted in 2016.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: University of Utah | Conditions: Adenomatous Polyposis Coli | Phase 2 | Status: COMPLETED | Results posted: 2016-06-17